Hospital Inpatient Mortality RW Dubois, WH Rogers, JH Moxley, D Draper, RH Brook RAND Corporation, 1991 | 471* | 1991 |
Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management A Brummel, A Lustig, K Westrich, MA Evans, GS Plank, J Penso, ... J Manag Care Pharm 20 (12), 1152-58, 2014 | 89 | 2014 |
Surveillance after polypectomy and after resection of colorectal cancer C Arditi, JJ Gonvers, B Burnand, G Minoli, D Oertli, F Lacaine, RW Dubois, ... Endoscopy 41 (3), 209-217, 2009 | 77 | 2009 |
Cost-effectiveness thresholds in the USA: are they coming? Are they already here? RW Dubois Journal of comparative effectiveness research 5 (1), 9-12, 2016 | 74 | 2016 |
Private sector risk-sharing agreements in the United States: trends, barriers, and prospects. LP Garrison, JJ Carlson, PS Bajaj, A Towse, PJ Neumann, SD Sullivan, ... The American journal of managed care 21 (9), 632-640, 2015 | 74 | 2015 |
Appropriateness studies. RW Dubois The New England journal of medicine 330 (6), 433; author reply 433-4, 1994 | 19* | 1994 |
Are ACOs ready to be accountable for medication use RW Dubois, M Feldman, A Lustig, G Kotzbauer, J Penso, SD Pope, ... J Manag Care Pharm 20 (1), 17-21, 2014 | 14 | 2014 |
Real-world impact of comparative effectiveness research findings on clinical practice. TB Gibson, ED Ehrlich, J Graff, R Dubois, AM Farr, M Chernew, ... The American journal of managed care 20 (6), e208-20, 2013 | 14* | 2013 |
Best Practices: An Electronic Drug Alert Program to Improve Safety in an Accountable Care Environment S Griesbach, A Lustig, L Malsin, B Carley, KD Westrich, RW Dubois Journal of managed care & specialty pharmacy 21 (4), 330-336, 2015 | 12 | 2015 |
When is evidence sufficient for decision-making? A framework for understanding the pace of evidence adoption RW Dubois, M Lauer, E Perfetto Journal of comparative effectiveness research 2 (4), 383-391, 2013 | 12 | 2013 |
Transparency in Evidence Evaluation And Formulary Decision-Making: From Conceptual Development to Real-World Implementation BB Dean, KJ Ko, JS Graff, AR Localio, R Wade, RW Dubois Pharmacy and Therapeutics 38 (8), 465, 2013 | 10 | 2013 |
From Conceptual Development to Real-World Implementation BB Dean, RW Dubois | 10* | |
The value of specialty pharmaceuticals-a systematic review. M Zalesak, JS Greenbaum, JT Cohen, F Kokkotos, A Lustig, PJ Neumann, ... The American journal of managed care 20 (6), 461-472, 2014 | 8 | 2014 |
From methods to policy: Enthusiasm for rapid-learning health systems exceeds the current standards for conducting it. NE McElwee, RW Dubois Journal of comparative effectiveness research 2 (5), 425, 2013 | 8 | 2013 |
Does type of bolus insulin matter in the hospital? Retrospective cohort analysis of outcomes between patients receiving analogue versus human insulin KJ Ko, V Tomor, BH Nathanson, JR Bouchard, M Aagren, RW Dubois Clinical therapeutics 32 (11), 1954-1966, 2010 | 8 | 2010 |
Adverse effects and reasons for switch reported by patients on antihypertensive medications K Chen, D Glass, CF Chiou, C Plauschinat, F Frech, A Harper, R Dubois American Journal of Hypertension 17 (5), S102, 2004 | 8 | 2004 |
The development of indications for the preoperative use of recombinant erythropoietin RW Dubois, D Lim, P Hebert, M Sherwood, GH Growe, JF Hardy, RE Park, ... Canadian journal of surgery 41 (5), 351, 1998 | 8 | 1998 |
Looking at CER from the pharmaceutical industry perspective RW Dubois Journal of Managed Care Pharmacy 18 (4), S9, 2012 | 7 | 2012 |
Solutions for filling gaps in accountable care measure sets. T Valuck, D Dugan, RW Dubois, K Westrich, J Penso, M McClellan The American journal of managed care 21 (10), 723-728, 2015 | 5 | 2015 |
Atypical nighttime symptoms of GERD among individuals with nighttime versus daytime GERD RW Dubois, R Fass, LF Johnson, D Aquilar, R Lynn, A Singh, M Tedeschi Gastroenterology 128 (4), A288-A288, 2005 | 5 | 2005 |